TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
University of Pittsburgh receives $1.3 million from the U.S. National Institutes of Health to develop bird flu vaccine
September 19th, 2006
The U.S. Institute of Allergy and Infectious Diseases (NIAID), of the U.S. National Institutes of Health in Bethesda, Md., has awarded a $1.3 million, two-year grant to the University of Pittsburgh School of Medicine to produce a promising avian flu vaccine that could be used in Phase I and Phase II human clinical trials. In January of this year, Pitt researchers reported in the journal Virology that their vaccine, which contains critical components of the deadly H5N1 virus but does not cause disease, completely protected mice and chickens from infection after exposure to the wild-type virus. According to Andrea Gambotto, MD, assistant...
Source: TB & Outbreaks Week (2006-09-19)
|
